B Lebkiri
About
In The Last Decade
B Lebkiri
11 papers receiving 312 citations
Peers
Comparison fields: 5 of 57
- Epidemiology 150
- Hepatology 146
- Clinical Biochemistry 61
- Nephrology 60
- Physiology 45
Countries citing papers authored by B Lebkiri
This map shows the geographic impact of B Lebkiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Lebkiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Lebkiri more than expected).
Fields of papers citing papers by B Lebkiri
This network shows the impact of papers produced by B Lebkiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Lebkiri. The network helps show where B Lebkiri may publish in the future.
Co-authorship network of co-authors of B Lebkiri
This figure shows the co-authorship network connecting the top 25 collaborators of B Lebkiri. A scholar is included among the top collaborators of B Lebkiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Lebkiri. B Lebkiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 65 | |
| 2 | [Preserved saphenous grafts in hemodialysis. 20 years' experience]. | 6 |
| 3 | 101 | |
| 4 | HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients. | 19 |
| 5 | Evaluation of parameters for adequate dialysis therapy: (1). Monitoring of parameters by urea kinetic modeling. | 3 |
| 6 | Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. | 43 |
| 7 | [Effect of keto analogs of essential amino acids on the progress of advanced chronic renal insufficiency: controlled prospective study]. | 2 |
| 8 | 71 | |
| 9 | Prevention of anti-N like antibodies development with nonformaldehyde reuse procedure. | 1 |
| 10 | [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)]. | 1 |
| 11 | 29 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.